The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 26, 2023

Filed:

Dec. 20, 2018
Applicant:

Ontario Institute for Cancer Research (Oicr), Toronto, CA;

Inventors:

Rima Al-awar, Toronto, CA;

Ahmed Mamai, Mississauga, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/18 (2006.01); C07D 215/42 (2006.01); C07D 223/16 (2006.01); C07D 311/68 (2006.01); C07D 335/06 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); A61K 38/07 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6889 (2017.08); A61K 38/07 (2013.01); A61K 45/06 (2013.01); A61K 47/6811 (2017.08); A61K 47/6855 (2017.08); A61P 35/00 (2018.01); C07D 215/42 (2013.01); C07D 223/16 (2013.01); C07D 311/68 (2013.01); C07D 335/06 (2013.01); C07D 498/18 (2013.01);
Abstract

The present application is directed to compounds of Formula (I): compounds of Formula (II): compounds of Formula (III): and compounds of Formula (IV): compositions comprising these compounds and their uses, for example as medicaments and/or diagnostics. Specifically claimed are: (1) compounds containing reactive functional groups (compound of formula I), compounds containing compounds to be linked together (compound of formula II) and compounds having a reactive functional group/a compound to be linked (compound of formula IV), (2) an antibody-drug conjugate (compound of formula III), wherein the antibody is covalently attached by a linker to one or more drugs, (3) pharmaceutical compositions comprising compounds of Formula (II) or Formula (III), (4) treatment/diagnosis of disease comprising compounds of Formula (II) or Formula (III), and (5) methods of preparing an ADC of Formula III.


Find Patent Forward Citations

Loading…